List of works - Ajay K Nooka

Belantamab mafodotin for relapsed or refractory multiple myeloma (DREAMM-2): a two-arm, randomised, open-label, phase 2 study

scientific article published on 16 December 2019

Clinical efficacy of daratumumab, pomalidomide, and dexamethasone in patients with relapsed or refractory myeloma: Utility of re-treatment with daratumumab among refractory patients

scientific article published on 15 May 2019

Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents

scientific article published on 14 April 2020

Daratumumab in multiple myeloma

scientific article published on 05 April 2019

Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

scientific article published in 2022

Early alterations in stem-like/resident T cells, innate and myeloid cells in the bone marrow in preneoplastic gammopathy

scientific article published on 23 April 2019

Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma

scientific article published on 06 March 2020

Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

scientific article published on 24 February 2020

Oral Selinexor-Dexamethasone for Triple-Class Refractory Multiple Myeloma

scientific article published on 01 August 2019

Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma

scientific article

Referral Patterns and Clinical Outcomes for Transplant-Eligible Lymphoma and Myeloma Patients Evaluated at an Urban County Hospital

scientific article published on 19 February 2016

Response to therapeutic monoclonal antibodies for multiple myeloma in African Americans versus whites

article

Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study

scientific article published on 23 February 2007

Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data